tiprankstipranks
Trending News
More News >
Amgen (DE:AMG)
XETRA:AMG
Germany Market

Amgen (AMG) Stock Forecast & Price Target

Compare
23 Followers
See the Price Targets and Ratings of:

AMG Analyst Ratings

Moderate Buy
24Ratings
Moderate Buy
12 Buy
11 Hold
1 Sell
Based on 24 analysts giving stock ratings to
Amgen
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

AMG Stock 12 Month Forecast

Average Price Target

€320.29
▲(2.18% Upside)
Based on 24 Wall Street analysts offering 12 month price targets for Amgen in the last 3 months. The average price target is €320.29 with a high forecast of €377.33 and a low forecast of €257.67. The average price target represents a 2.18% change from the last price of €313.45.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"231":"€231","378":"€378","267.75":"€267.8","304.5":"€304.5","341.25":"€341.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":377.33047344,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€377.33</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":320.294177339,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€320.29</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":257.66780015,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€257.67</span>\n  </div></div>","useHTML":true}}],"tickPositions":[231,267.75,304.5,341.25,378],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jun<br/>2025","6":"Sep<br/>2025","9":"Dec<br/>2025","12":"Mar<br/>2026","25":"Mar<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,329.2,332.9023441107692,336.6046882215384,340.3070323323077,344.0093764430769,347.71172055384613,351.41406466461535,355.1164087753846,358.81875288615385,362.52109699692306,366.2234411076923,369.92578521846156,373.6281293292308,{"y":377.33047344,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,329.2,328.5149367183846,327.8298734367692,327.14481015515383,326.45974687353845,325.77468359192306,325.0896203103077,324.4045570286923,323.7194937470769,323.0344304654615,322.34936718384614,321.66430390223076,320.97924062061537,{"y":320.294177339,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,329.2,323.69752308846154,318.1950461769231,312.6925692653846,307.1900923538461,301.6876154423077,296.1851385307692,290.68266161923077,285.1801847076923,279.67770779615387,274.1752308846154,268.6727539730769,263.17027706153846,{"y":257.66780015,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":283.999,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 32,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":280.12,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":246.475,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 20, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":246.444,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 35,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 29, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":232.405,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 34,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 28, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":249.771,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 40,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 37, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":243.227,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 39, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":252.448,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 33,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 40, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":252.004,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 38,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 31, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":289.392,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 41,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":278.369,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 41,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":289.889,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 81,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 38, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":329.2,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 73,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 39, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target€377.33Average Price Target€320.29Lowest Price Target€257.67
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Bernstein
€292.61
Hold
-6.65%
Downside
Reiterated
03/12/26
Bernstein Sticks to Their Hold Rating for Amgen (AMGN)
Barclays Analyst forecast on DE:AMG
Barclays
Barclays
€305.71
Hold
-2.47%
Downside
Assigned
03/12/26
Barclays Reaffirms Their Hold Rating on Amgen (AMGN)
TD Cowen Analyst forecast on DE:AMG
TD Cowen
TD Cowen
€339.77€366.85
Buy
17.04%
Upside
Reiterated
03/11/26
Jefferies Analyst forecast on DE:AMG
Jefferies
Jefferies
€305.71
Hold
-2.47%
Downside
Initiated
03/10/26
Amgen initiated with a Hold at JefferiesAmgen initiated with a Hold at Jefferies
Truist Financial Analyst forecast on DE:AMG
Truist Financial
Truist Financial
Hold
Reiterated
03/04/26
Analysts Offer Insights on Healthcare Companies: Amgen (NASDAQ: AMGN), ANI Pharmaceuticals (NASDAQ: ANIP) and ALX Oncology Holdings (NASDAQ: ALXO)
Piper Sandler Analyst forecast on DE:AMG
Piper Sandler
Piper Sandler
€377.33
Buy
20.38%
Upside
Reiterated
03/03/26
Analysts Offer Insights on Healthcare Companies: Radnet (NASDAQ: RDNT), Amgen (NASDAQ: AMGN) and Eli Lilly & Co (NYSE: LLY)
Wells Fargo Analyst forecast on DE:AMG
Wells Fargo
Wells Fargo
€283.87€327.54
Hold
4.50%
Upside
Reiterated
02/19/26
Amgen price target raised to $375 from $325 at Wells FargoAmgen price target raised to $375 from $325 at Wells Fargo
Mizuho Securities Analyst forecast on DE:AMG
Mizuho Securities
Mizuho Securities
€244.57€257.67
Hold
-17.80%
Downside
Reiterated
02/11/26
Amgen price target raised to $295 from $280 at MizuhoAmgen price target raised to $295 from $280 at Mizuho
Argus Research Analyst forecast on DE:AMG
Unknown Analyst
Argus Research
Not Ranked
Argus Research
€349.38
Buy
11.46%
Upside
Reiterated
02/06/26
Amgen (AMGN) Receives a Buy from Argus Research
Guggenheim Analyst forecast on DE:AMG
Unknown Analyst
Guggenheim
Not Ranked
Guggenheim
€266.4€303.09
Hold
-3.31%
Downside
Reiterated
02/05/26
Guggenheim Remains a Hold on Amgen (AMGN)
Citi
€275.14€301.34
Hold
-3.86%
Downside
Reiterated
02/04/26
Amgen: Solid New-Product Uptake Offset by Legacy Erosion and Execution Risks, Warranting a Hold Rating
Morgan Stanley Analyst forecast on DE:AMG
Morgan Stanley
Morgan Stanley
€265.53€269.9
Hold
-13.90%
Downside
Reiterated
02/04/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Amgen (NASDAQ: AMGN), Caribou Biosciences (NASDAQ: CRBU) and Boston Scientific (NYSE: BSX)
BMO Capital Analyst forecast on DE:AMG
BMO Capital
BMO Capital
€324.92
Buy
3.66%
Upside
Reiterated
02/04/26
Analysts Offer Insights on Healthcare Companies: Amgen (NASDAQ: AMGN), Pfizer (NYSE: PFE) and Merck & Company (NYSE: MRK)
Goldman Sachs Analyst forecast on DE:AMG
Goldman Sachs
Goldman Sachs
€362.48
Buy
15.64%
Upside
Reiterated
02/04/26
Analysts Offer Insights on Healthcare Companies: Amgen (NASDAQ: AMGN) and Johnson & Johnson (NYSE: JNJ)
Cantor Fitzgerald Analyst forecast on DE:AMG
Cantor Fitzgerald
Cantor Fitzgerald
€275.14€305.71
Hold
-2.47%
Downside
Reiterated
02/04/26
Cantor Fitzgerald Sticks to Its Hold Rating for Amgen (AMGN)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Bernstein
€292.61
Hold
-6.65%
Downside
Reiterated
03/12/26
Bernstein Sticks to Their Hold Rating for Amgen (AMGN)
Barclays Analyst forecast on DE:AMG
Barclays
Barclays
€305.71
Hold
-2.47%
Downside
Assigned
03/12/26
Barclays Reaffirms Their Hold Rating on Amgen (AMGN)
TD Cowen Analyst forecast on DE:AMG
TD Cowen
TD Cowen
€339.77€366.85
Buy
17.04%
Upside
Reiterated
03/11/26
Jefferies Analyst forecast on DE:AMG
Jefferies
Jefferies
€305.71
Hold
-2.47%
Downside
Initiated
03/10/26
Amgen initiated with a Hold at JefferiesAmgen initiated with a Hold at Jefferies
Truist Financial Analyst forecast on DE:AMG
Truist Financial
Truist Financial
Hold
Reiterated
03/04/26
Analysts Offer Insights on Healthcare Companies: Amgen (NASDAQ: AMGN), ANI Pharmaceuticals (NASDAQ: ANIP) and ALX Oncology Holdings (NASDAQ: ALXO)
Piper Sandler Analyst forecast on DE:AMG
Piper Sandler
Piper Sandler
€377.33
Buy
20.38%
Upside
Reiterated
03/03/26
Analysts Offer Insights on Healthcare Companies: Radnet (NASDAQ: RDNT), Amgen (NASDAQ: AMGN) and Eli Lilly & Co (NYSE: LLY)
Wells Fargo Analyst forecast on DE:AMG
Wells Fargo
Wells Fargo
€283.87€327.54
Hold
4.50%
Upside
Reiterated
02/19/26
Amgen price target raised to $375 from $325 at Wells FargoAmgen price target raised to $375 from $325 at Wells Fargo
Mizuho Securities Analyst forecast on DE:AMG
Mizuho Securities
Mizuho Securities
€244.57€257.67
Hold
-17.80%
Downside
Reiterated
02/11/26
Amgen price target raised to $295 from $280 at MizuhoAmgen price target raised to $295 from $280 at Mizuho
Argus Research Analyst forecast on DE:AMG
Unknown Analyst
Argus Research
Not Ranked
Argus Research
€349.38
Buy
11.46%
Upside
Reiterated
02/06/26
Amgen (AMGN) Receives a Buy from Argus Research
Guggenheim Analyst forecast on DE:AMG
Unknown Analyst
Guggenheim
Not Ranked
Guggenheim
€266.4€303.09
Hold
-3.31%
Downside
Reiterated
02/05/26
Guggenheim Remains a Hold on Amgen (AMGN)
Citi
€275.14€301.34
Hold
-3.86%
Downside
Reiterated
02/04/26
Amgen: Solid New-Product Uptake Offset by Legacy Erosion and Execution Risks, Warranting a Hold Rating
Morgan Stanley Analyst forecast on DE:AMG
Morgan Stanley
Morgan Stanley
€265.53€269.9
Hold
-13.90%
Downside
Reiterated
02/04/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Amgen (NASDAQ: AMGN), Caribou Biosciences (NASDAQ: CRBU) and Boston Scientific (NYSE: BSX)
BMO Capital Analyst forecast on DE:AMG
BMO Capital
BMO Capital
€324.92
Buy
3.66%
Upside
Reiterated
02/04/26
Analysts Offer Insights on Healthcare Companies: Amgen (NASDAQ: AMGN), Pfizer (NYSE: PFE) and Merck & Company (NYSE: MRK)
Goldman Sachs Analyst forecast on DE:AMG
Goldman Sachs
Goldman Sachs
€362.48
Buy
15.64%
Upside
Reiterated
02/04/26
Analysts Offer Insights on Healthcare Companies: Amgen (NASDAQ: AMGN) and Johnson & Johnson (NYSE: JNJ)
Cantor Fitzgerald Analyst forecast on DE:AMG
Cantor Fitzgerald
Cantor Fitzgerald
€275.14€305.71
Hold
-2.47%
Downside
Reiterated
02/04/26
Cantor Fitzgerald Sticks to Its Hold Rating for Amgen (AMGN)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Amgen

3 Months
xxx
Success Rate
11/15 ratings generated profit
73%
Average Return
+7.04%
reiterated a xxx
rating 17 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 73.33% of your transactions generating a profit, with an average return of +7.04% per trade.
1 Year
David AmsellemPiper Sandler
Success Rate
14/15 ratings generated profit
93%
Average Return
+21.91%
reiterated a buy rating 17 days ago
Copying David Amsellem's trades and holding each position for 1 Year would result in 93.33% of your transactions generating a profit, with an average return of +21.91% per trade.
2 Years
xxx
Success Rate
15/15 ratings generated profit
100%
Average Return
+28.40%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +28.40% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

AMG Analyst Recommendation Trends

Rating
Nov 25
Dec 25
Jan 26
Feb 26
Mar 26
Strong Buy
0
0
0
0
0
Buy
38
41
41
81
73
Hold
31
21
19
38
39
Sell
2
1
3
2
2
Strong Sell
0
0
0
0
0
total
71
63
63
121
114
In the current month, AMG has received 73 Buy Ratings, 39 Hold Ratings, and 2 Sell Ratings. AMG average Analyst price target in the past 3 months is 320.29.
Each month's total comprises the sum of three months' worth of ratings.

AMG Financial Forecast

AMG Earnings Forecast

Next quarter’s earnings estimate for AMG is €4.16 with a range of €3.62 to €5.33. The previous quarter’s EPS was €4.59. AMG beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year AMG has Performed in-line its overall industry.
Next quarter’s earnings estimate for AMG is €4.16 with a range of €3.62 to €5.33. The previous quarter’s EPS was €4.59. AMG beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year AMG has Performed in-line its overall industry.

AMG Sales Forecast

Next quarter’s sales forecast for AMG is €7.46B with a range of €7.22B to €8.03B. The previous quarter’s sales results were €8.58B. AMG beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.17% of the time in the same period. In the last calendar year AMG has Performed in-line its overall industry.
Next quarter’s sales forecast for AMG is €7.46B with a range of €7.22B to €8.03B. The previous quarter’s sales results were €8.58B. AMG beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.17% of the time in the same period. In the last calendar year AMG has Performed in-line its overall industry.

AMG Stock Forecast FAQ

What is DE:AMG’s average 12-month price target, according to analysts?
Based on analyst ratings, Amgen’s 12-month average price target is 320.29.
    What is DE:AMG’s upside potential, based on the analysts’ average price target?
    Amgen has 2.18% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Amgen a Buy, Sell or Hold?
          Amgen has a consensus rating of Moderate Buy, which is based on 12 buy ratings, 11 hold ratings and 1 sell ratings.
            What is Amgen’s share price target?
            The average share price target for Amgen is 320.29. This is based on 24 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is €377.33 ,and the lowest forecast is €257.67. The average share price target represents 2.18% Increase from the current price of €313.45.
              What do analysts say about Amgen?
              Amgen’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 24 Wall Streets Analysts.
                How can I buy shares of Amgen?
                To buy shares of DE:AMG, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.